Increasing Transparency at the US Food and Drug Administration

被引:1
|
作者
Steinbrook, Robert [1 ]
机构
[1] Univ Calif San Francisco, Sch Med, 505 Parnassus Ave,Ste M1180,Box 0124, San Francisco, CA 94143 USA
关键词
D O I
10.1001/jamainternmed.2019.1194
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1146 / 1147
页数:2
相关论文
共 50 条
  • [1] Transparency at the US Food and Drug Administration
    Califf, Robert M.
    JOURNAL OF LAW MEDICINE & ETHICS, 2017, 45 : 24 - 28
  • [2] Blueprint for Transparency at the US Food and Drug Administration
    McClellan, Courtney
    JOURNAL OF LAW MEDICINE & ETHICS, 2017, 45 : 1 - 1
  • [3] Blueprint for Transparency at the US Food and Drug Administration INTRODUCTION
    Davis, Anna L.
    Miller, James Dabney
    Sharfstein, Joshua M.
    Kesselheim, Aaron S.
    JOURNAL OF LAW MEDICINE & ETHICS, 2017, 45 : 5 - 6
  • [4] Another Reason for Greater Transparency at the US Food and Drug Administration
    Steinbrook, Robert
    JAMA INTERNAL MEDICINE, 2021, 181 (04) : 529 - 529
  • [5] Assessment of Public Opinion on Transparency at the US Food and Drug Administration
    Azad, Tej D.
    Plott, Caroline F.
    Gielen, Andrea C.
    Sharfstein, Joshua M.
    JAMA NETWORK OPEN, 2022, 5 (02)
  • [6] Transparency and Dermatologic Device Approval by the US Food and Drug Administration
    Ezaldein, Harib H.
    Scott, Jeffrey F.
    Yin, Emily S.
    Ventura, Alessandra
    DeRuyter, Nicholaas P.
    Leffell, David J.
    JAMA DERMATOLOGY, 2018, 154 (03) : 273 - 280
  • [7] Transparency at the Food and Drug Administration.
    Asamoah, Afia K.
    Sharfstein, Joshua M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2010, 362 (25): : 2341 - 2343
  • [8] US food and drug administration
    Goodman, Jesse
    ONCOLOGY-NEW YORK, 2006, 20 (08): : 946 - 946
  • [9] US Food and Drug Administration
    Blumenthal, G.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S37 - S37
  • [10] US Food and Drug Administration Updates
    Sahin, L.
    BIRTH DEFECTS RESEARCH, 2018, 110 (09): : 748 - 748